Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00023595 · ClinicalTrials.gov registry record · Phase 3
Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease
A Phase 3 study of Cardiovascular Diseases and Heart Diseases, sponsored by Duke University.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,136
- Enrollment target
- 1
- Study location
NCT00023595 is a Phase 3 study of Cardiovascular Diseases and Heart Diseases that has completed, run by Duke University. The registered enrollment target is 2,136 participants, below the 26,967-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00023595, a Phase 3 study of Cardiovascular Diseases and Heart Diseases, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,136 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare medical therapy with coronary bypass surgery and/or surgical ventricular reconstruction for patients with congestive heart failure and coronary artery disease (CAD).
Conditions Studied
Interventions
- PROCEDURE CABG surgery plus MED
- DRUG Active Medication Alone
- PROCEDURE CABG plus MED and SVR
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,136 participants |
| Start Date | 2002-01 |
| Est. Completion | 2015-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00023595
The ClinicalTrials.gov registry entry for NCT00023595 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 2,136 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,967-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (92% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 3 interventions - of which CABG surgery plus MED is the first listed.
NCT00023595 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT00023595 about?
NCT00023595 is a clinical study titled "Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease". This study will compare medical therapy with coronary bypass surgery and/or surgical ventricular reconstruction for patients with congestive heart failure and coronary artery disease (CAD).
What is the current status of trial NCT00023595?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,136 participants. The study started on 2002-01. Estimated completion is 2015-11.
What conditions does trial NCT00023595 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Heart Diseases, Coronary Disease, Heart Failure, Congestive.
What interventions are being tested in trial NCT00023595?
The interventions under investigation include: CABG surgery plus MED (PROCEDURE), Active Medication Alone (DRUG), CABG plus MED and SVR (PROCEDURE).
Who is sponsoring clinical trial NCT00023595?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00023595 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care
RECRUITING · Phase 3
-
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RECRUITING · Phase 3
-
Cardiovascular Effects of a Healthy Dietary Pattern Containing Eggs
RECRUITING · Phase 3
-
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
ACTIVE NOT RECRUITING · Phase 3
-
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
ACTIVE NOT RECRUITING · Phase 3
-
Comparison of Hematocrit Levels in Infant Heart Surgery
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.